India.com News Desk | Dec 21, 2021, 10:57 PM IST
WHO said Nuvaxovid was around 90 per cent effective at reducing symptomatic cases of COVID-19 in two major clinical studies.
India.com News Desk | Dec 17, 2021, 9:05 PM IST
WHO on Friday granted Emergency Use Listing to Covovax, the coronavirus vaccine developed by the Serum Institute of India in partnership with the US-based Novavax.
India.com News Desk | Oct 20, 2021, 10:44 AM IST
They discussed the pending emergency use listing (EUL) of Bharat Biotech's COVID-19 vaccine Covaxin by the WHO and resumption of supplies of the Serum Institute of India-manufactured AstraZeneca vaccine Covishield to the COVAX facility among other topics.
India.com News Desk | Jun 17, 2021, 7:47 PM IST
Bharat Biotech, COVAXIN maker, on Thursday, trashed the media reports claiming that the company has submitted the Phase-3 date of the vaccine to the World Health Organisation (WHO).
India.com News Desk | May 25, 2021, 8:27 PM IST
Unvaccinated travellers can travel with negative RT-PCR tests prior to travel, in the absence of any other country-specific travel restrictions, Bharat Biotech said.
English
